CannabisNewsBreaks

WednesdayFeb 02, 2022 2:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Significant Findings from Sildenafil Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor ("PDE5 inhibitor") sildenafil for potential use in the management of erectile dysfunction. According to the company, the DehydraTECHsildenafil delivered 74% more drug at four minutes than the concentration-matched, generic control formulation with faster and higher overall delivery of sildenafil into the bloodstream evidenced over the course of the study. The most recognizable sildenafil product available currently is Viagra(R), but some users find it slow to act. Lexaria hopes…

Continue Reading

WednesdayFeb 02, 2022 12:37 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Seeks Approval to Study Patent-Pending Cannabinoid-Based Product to Treat COVID-19

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies indicate the potential for cannabinoids to display viral inhibition. FLGC’s research division, Flora Pharma, has filed a USPTO provisional patent application regarding the company’s cannabinoid-based formula, and the company is hoping to take the product through clinical trials under an emergency use authorization (“EUA”) from INVIMA.According to the company, the intent of the study is to identify safe and efficacious…

Continue Reading

TuesdayFeb 01, 2022 1:49 pm

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy…

Continue Reading

FridayJan 28, 2022 11:12 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Closing of Embark Acquisition

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an innovative health and wellness beverages and products company, has closed on its acquisition of Embark Health Inc., solventless cannabis extraction and delivery technology provider. According to the company, the acquisition will be a significant driver of growth for BevCanna, accelerating its already strong upward trajectory. Embark owns a unique range of brands across all three cannabis 2.0 categories, meaning that BevCanna will now be able to sell differentiated and complementary adult-use and wellness products. In addition, Embark brings a British-Columbia-based, state-of-the-art production facility with $17 million  in tangible and intangible assets to…

Continue Reading

ThursdayJan 27, 2022 12:33 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to improve the company’s understanding of the capabilities of its ground-breaking DehydraTECH(TM) drug-delivery technology to enhance its abilities to commercialize and profit from this technology platform. “DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform,” Bunka explains in the letter. “Expecting entire industries to change overnight to adopt a revolutionary new process is…

Continue Reading

ThursdayJan 27, 2022 11:09 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Award-Winning Expert as SVP of Global Operations

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its appointment of operations and personnel development expert, Joël Reyes, as senior vice president of global operations. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” said Luis Merchan, president and CEO of Flora Growth Corp.…

Continue Reading

ThursdayJan 27, 2022 10:31 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement

RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet's patients using RYAH Smart Inhalers and data analytics, once certified as a medical device in Israel, with the goal of providing safe and accurate patient inhalation therapies in plant medicine. “Bazelet brings extraordinary depth and expertise within a well-established and fast-growing medical cannabis market. We're excited to be collaborating with Bazelet in bringing our smart…

Continue Reading

WednesdayJan 26, 2022 1:39 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strategically Pursuing Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is riding the popularity of its trademarked Platinum Vape to remarkable revenue growth, recording a 93% year-over-year increase in its recently released third-quarter financial report. “The financial results note that the majority of the company’s revenue comes from sales of cannabis finished products through third-party wholesaling to retailers, delivering quarterly revenue of $11.8 million and EBITDA of $5.9 million that reverses an EBITDA loss of $5.8 million in Q3 2020 for a gain of $11.9 million,” reads a recent article, which also includes comments by RWB chairman and CEO Brad Rogers…

Continue Reading

TuesdayJan 25, 2022 1:22 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Submits NNCP Filing with Health Canada

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, announced that it has filed Form 8-K with Health Canada; the filing is GPFT’s Notice of New Cannabis Product (“NNCP”) with Health Canada. Once GPFT receives approval of the NNCP from Health Canada, the company will be able to offer its patented Hourglass(TM) Time Release THC+CBD-Infused Topical Delivery Cream under the Canadian Federal Cannabis Act throughout Canada. The act, which became effective in 2018, provides national guidelines for legal access to cannabis as well as the product, distribution and sale of the substance. Canada became the second country in the world…

Continue Reading

TuesdayJan 25, 2022 1:11 pm

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Strategic Distribution Agreement Between Wholly Owned cDistro and dosist health

Marijuana Company of America (OTC: MCOA), a diversified holding company with operations and investments throughout the cannabis industry, today announced that its wholly owned subsidiary cDistro has reached an agreement with dosist health to distribute its award-winning line of high concentration CBD+ formulas and products. According to the update, cDistro will expand the rapidly growing distribution locations for dosist health CBD products to drive sales and further establish cDistro in the distribution marketplace. “This agreement represents a tremendous opportunity for cDistro,” said cDistro's President Ron Russo. “I look forward to working with dosist health and their award-winning product portfolio to…

Continue Reading